UBS downgrades Carlyle as weak fund returns threaten 2028 growth targets

UBS downgraded Carlyle Group to Neutral, cutting its price target to $47 from $60. The firm cited weaker private equity fund performance and delayed fundraising, which may hinder Carlyle's 2028 targets. UBS forecasts fee-related earnings of $1.68B, below Carlyle's $1.9B goal. Fundraising delays and smaller, growing businesses also pose challenges.

Original reporting
Published Nov 10, 2026, 1:47 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 10, 2026, 1:55 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$CG
Bearish
high confidence
Mentioned
$CG
Relevance
7/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$CGBearishMed
01

Why it matters

The downgrade may trigger short‑selling and reduce inflows into Carlyle‑focused funds, while competitors like Apollo and TPG could attract reallocations.

02

Market read

Analyst downgrade with a sizable price‑target cut is a fresh catalyst that can move CG lower in the short term.

03

What to watch

Potential upside from emerging private‑credit products and a rebound in fundraising cycles later in 2027.

Relevance 7/10Novelty 8/10Timing: today

Background

UBS analysts lowered Carlyle's growth forecasts after observing sub‑mid‑teens IRR on its flagship funds and delayed capital deployment for upcoming vehicles.

Company-level read

Ticker impact

$CGBearishHigh confidence
Context

UBS downgraded Carlyle Group to Neutral and cut its 12‑month price target to $47, citing weaker fund performance and delayed fundraising.

Expected impact

downward pressure as investors price in slower growth and reduced fee‑related earnings.

Evidence & confidence

Analyst downgrade with a 23% price‑target cut is a concrete catalyst that typically drives the stock lower.

Market effects

Private‑equity sector may see broader valuation pressure as peers reassess fundraising outlooks.

U.S. markets could see a modest dip in financials focused on alternative assets.

Limited to firms with exposure to private‑equity fee‑related earnings.

Counterpoint

Carlyle's diversification into wealth management, insurance, and private credit could mitigate near‑term earnings slowdown.

Key entities

  • Carlyle Group

    Global alternative‑asset manager (ticker CG).

  • UBS

    Investment bank providing the downgrade and new price target.

Related articles

$CGHigh

Why is Carlyle stock sliding today?

Carlyle Group (CG) stock fell 0.8% to $41.99 in pre-market trading after UBS downgraded it to Neutral, cutting its price target to $47 from $60. UBS cited reduced confidence in Carlyle's growth trajectory and ability to meet 2028 financial targets. Other analysts have also lowered price targets. The stock is below its 52-week high of $67.30 but above its low of $35.41.

$CGHigh

UBS downgrades Carlyle Group stock rating on growth concerns

UBS downgraded Carlyle Group (CG) from Buy to Neutral, lowering its price target to $47. Analysts cited concerns about growth and reduced fee-related earnings forecasts. The stock is down 26.9% year-to-date, trading at $42.31. UBS also lowered its 2027 and 2028 earnings estimates. Carlyle's Q3 2026 results beat expectations but the stock declined due to growth outlook uncertainties.

$CGMed

Carlyle Group Targets First Buyout Fund Close as $200 Billion Fundraising Push Takes Shape

Carlyle Group (CG) aims to close its first buyout fund as part of a $200 billion fundraising initiative. The company announced its first defense fund deal, Secturion, and highlighted a $5 billion structured transaction via AlpInvest. Carlyle expects growth in credit secondaries and fee-related earnings, with a focus on private equity products. The firm is also restructuring its European buyout team, with the next fund expected to be smaller than its predecessor.

$CGMed

Carlyle and EBRD Agree Sale

Carlyle (CG) and EBRD agreed to sell Black Sea Oil & Gas (BSOG), Romania's largest offshore gas producer, to Mazarine Energy. The deal, pending approval, transfers ownership of BSOG, which supplies 12% of Romania's gas demand, to Mazarine. Carlyle invested over $400M in BSOG's Midia Gas Development project. BSOG will remain the operator, ensuring continuity.

$CGHighAI 8/10

Carlyle 3Q 2026: Revenue $334.1M, EPS ($0.02) — 10-Q Summary

Carlyle reported Q3 2026 revenue of $334.1M, a slight YoY decrease, and a net loss of $0.02 per share. Fund management fees and performance allocations declined, while principal investment income and compensation expenses fell. Distributable earnings rose to $432.5M, with $11.0B deployed and $10.8B in inflows. AUM totaled $478.5B.